Daratumumab and hyaluronidase
Generic name: daratumumab and hyaluronidase [ DAR-a-TOOM-ue-mab-and-HYE-al-ure-ON-i-dase-o ]
Brand name: Darzalex Faspro
Dosage form: subcutaneous solution (1800 mg-30,000 units/15 mL)
Drug class:CD38 monoclonal antibodies
What is daratumumab and hyaluronidase?
Daratumumab and hyaluronidase is used to treat multiple myeloma in adults.
Daratumumab and hyaluronidase is sometimes used in combination with other medicines.
Daratumumab and hyaluronidase may also be used for purposes not listed in this medication guide.
Warnings
daratumumab and hyaluronidase may harm an unborn baby. Use effective birth control to prevent pregnancy while using daratumumab and hyaluronidase and for at least 3 months after your last dose.
Carefully follow all instructions about the use of birth control while you are using daratumumab and hyaluronidase in combination with other medicines.
Before taking this medicine
You should not use this medicine if you are allergic to daratumumab or hyaluronidase.
Tell your doctor if you have ever had:
breathing problems;
hepatitis B; or
Daratumumab and hyaluronidase may harm an unborn baby. Use effective birth control to prevent pregnancy while using this medicine and for at least 3 months after your last dose. Tell your doctor if you become pregnant.
Daratumumab and hyaluronidase is sometimes used in combination with lenalidomide. Both men and women using lenalidomide must use effective birth control. Even one dose can cause severe, life-threatening birth defects or death of a baby if the mother or the father is taking lenalidomide at the time of conception or during pregnancy.
Carefully follow all instructions about the use of birth control while you are using daratumumab and hyaluronidase in combination with other medicines.
How is daratumumab and hyaluronidase given?
Daratumumab and hyaluronidase is injected under the skin. A healthcare provider will give you this injection over a period of 3 to 5 minutes.
You may be given other medications to help prevent serious side effects or an allergic reaction. Keep using these medicines for as long as your doctor has prescribed.
Daratumumab and hyaluronidase is usually given every 1 to 4 weeks until your body no longer responds to the medicine. Your doctor will determine how long to treat you with daratumumab and hyaluronidase, and how often you will receive an injection.<...
